Table 1 Baseline characteristics of 137 subjects in the LANDMARK 2 study
Characteristics | Value |
|---|---|
Age (yrs) | 53.4 ± 11.1 |
Sex M/F, n | 85/52 |
Body mass index (kg/m2) | 28.1 ± 5.4 |
Abnormal glucose tolerance, n (%) | 102 (75) |
Duration of transplant (yrs) | 7.8 (0.5-31.9) |
Hypertension, n (%) | 125 (91) |
Systolic blood pressure (mmHg) | 132.6 ± 15.2 |
Diastolic blood pressure (mmHg) | 77.7 ± 10.5 |
CKD stage, n (%) | |
1 (>90 mls/min) | 13 (9.5) |
2 (60-90 mls/min) | 79 (57.7) |
3 (30-60 mls/min) | 40 (29.2) |
4 (15-30 mls/min) | 5 (3.7) |
MDRD Glomerular filtration rate (mls/min/1.73 m2) | 51.8 ± 18.3 |
Fasting glucose (mmol/L) | |
-Abnormal glucose tolerance group | 6.1 ± 2.2 |
-Normal glucose tolerance group | 4.9 ± 4.5 |
Fasting cholesterol (mmol/L) | 4.9 ± 1.1 |
Fasting triglyceride (mmol/L) | 1.9 ± .9 |
C-reactive protein (mg/L) | 8.0 ± 12.6 |
Adiponectin (μg/mL) | 12.3 ± 7.1 |
Metabolic syndrome, n (%) | 59 (43.1) |
Combined baseline cardiovascular events (ACS, MI, CABG, stroke, PVD), n (%) | 35 (26) |